Connection

MASATAKA SUZUKI to Animals

This is a "connection" page, showing publications MASATAKA SUZUKI has written about Animals.
Connection Strength

0.789
  1. Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. J Immunother Cancer. 2024 Dec 09; 12(12).
    View in: PubMed
    Score: 0.051
  2. Identification and functional analysis of sex-determining genes in the spongy moth, Lymantria dispar (lepidoptera: Erebidae). Insect Biochem Mol Biol. 2025 Feb; 177:104219.
    View in: PubMed
    Score: 0.050
  3. Bispecific antibodies and autologous chimeric antigen receptor T?cell therapies for treatment of hematological malignancies. Mol Ther. 2024 Aug 07; 32(8):2444-2460.
    View in: PubMed
    Score: 0.049
  4. Effects of cattle manure compost application on crop growth and soil-to-crop transfer of cesium in a physically radionuclide-decontaminated field. Sci Total Environ. 2024 Jan 15; 908:167939.
    View in: PubMed
    Score: 0.047
  5. Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Sci Adv. 2023 03 29; 9(13):eade6790.
    View in: PubMed
    Score: 0.045
  6. Host-microbe cross-talk governs amino acid chirality to regulate survival and differentiation of B cells. Sci Adv. 2021 03; 7(10).
    View in: PubMed
    Score: 0.039
  7. Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Mol Ther. 2020 05 06; 28(5):1251-1262.
    View in: PubMed
    Score: 0.036
  8. Serum D-serine accumulation after proximal renal tubular damage involves neutral amino acid transporter Asc-1. Sci Rep. 2019 11 13; 9(1):16705.
    View in: PubMed
    Score: 0.036
  9. Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment. Front Immunol. 2018; 9:2103.
    View in: PubMed
    Score: 0.033
  10. Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Mol Ther. 2017 11 01; 25(11):2440-2451.
    View in: PubMed
    Score: 0.031
  11. Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Res. 2017 04 15; 77(8):2040-2051.
    View in: PubMed
    Score: 0.029
  12. Glycolytic flux controls D-serine synthesis through glyceraldehyde-3-phosphate dehydrogenase in astrocytes. Proc Natl Acad Sci U S A. 2015 Apr 28; 112(17):E2217-24.
    View in: PubMed
    Score: 0.026
  13. Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo. Mol Ther. 2013 Apr; 21(4):796-805.
    View in: PubMed
    Score: 0.022
  14. NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo. Hum Gene Ther. 2011 Sep; 22(9):1071-82.
    View in: PubMed
    Score: 0.020
  15. MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus. Hum Gene Ther. 2010 Mar; 21(3):325-36.
    View in: PubMed
    Score: 0.018
  16. ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression. Mol Ther. 2009 Apr; 17(4):707-15.
    View in: PubMed
    Score: 0.017
  17. Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals. Mol Ther. 2008 Oct; 16(10):1727-36.
    View in: PubMed
    Score: 0.016
  18. Early STAT1 activation after systemic delivery of HSV amplicon vectors suppresses transcription of the vector-encoded transgene. Mol Ther. 2007 Nov; 15(11):2017-26.
    View in: PubMed
    Score: 0.015
  19. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. J Virol. 2006 Apr; 80(7):3293-300.
    View in: PubMed
    Score: 0.014
  20. Mammalian Tolerance to Amino Acid Heterochirality. Chembiochem. 2025 Jul 11; 26(13):e202500273.
    View in: PubMed
    Score: 0.013
  21. The Masc-PSI complex directly induces male-type doublesex splicing in silkworms. Commun Biol. 2025 Jun 14; 8(1):927.
    View in: PubMed
    Score: 0.013
  22. Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens. mBio. 2025 Feb 05; 16(2):e0341224.
    View in: PubMed
    Score: 0.013
  23. Mouse enteric neurons control intestinal plasmacytoid dendritic cell function via serotonin-HTR7 signaling. Nat Commun. 2024 10 25; 15(1):9237.
    View in: PubMed
    Score: 0.013
  24. Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In?Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors. Immunohorizons. 2024 08 01; 8(8):598-605.
    View in: PubMed
    Score: 0.012
  25. H3.1/3.2 regulate the initial progression of the gene expression program. Nucleic Acids Res. 2024 Jun 24; 52(11):6158-6170.
    View in: PubMed
    Score: 0.012
  26. Integration of ?-deficient CARs into the CD3? gene conveys potent cytotoxicity in T and NK cells. Blood. 2024 06 20; 143(25):2599-2611.
    View in: PubMed
    Score: 0.012
  27. A multi-hierarchical approach reveals d-serine as a hidden substrate of sodium-coupled monocarboxylate transporters. Elife. 2024 Apr 23; 12.
    View in: PubMed
    Score: 0.012
  28. Genetic and immune determinants of E. coli liver abscess formation. Proc Natl Acad Sci U S A. 2023 Dec 19; 120(51):e2310053120.
    View in: PubMed
    Score: 0.012
  29. Involvement of linker histone variant H1a in the regulation of early preimplantation development in mice. J Reprod Dev. 2023 Jun 06; 69(3):178-182.
    View in: PubMed
    Score: 0.011
  30. Mammals sustain amino acid homochirality against chiral conversion by symbiotic microbes. Proc Natl Acad Sci U S A. 2023 04 11; 120(15):e2300817120.
    View in: PubMed
    Score: 0.011
  31. Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820.
    View in: PubMed
    Score: 0.010
  32. Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice. Mol Genet Metab. 2016 Mar; 117(3):378-82.
    View in: PubMed
    Score: 0.007
  33. Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers. Mol Ther. 2015 Sep; 23(9):1497-506.
    View in: PubMed
    Score: 0.007
  34. Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer. J Innate Immun. 2015; 7(3):302-14.
    View in: PubMed
    Score: 0.006
  35. Ischemic acute kidney injury perturbs homeostasis of serine enantiomers in the body fluid in mice: early detection of renal dysfunction using the ratio of serine enantiomers. PLoS One. 2014; 9(1):e86504.
    View in: PubMed
    Score: 0.006
  36. Capsid-modified adenoviral vectors for improved muscle-directed gene therapy. Hum Gene Ther. 2012 Oct; 23(10):1065-70.
    View in: PubMed
    Score: 0.005
  37. Cytokine-conditioned dendritic cells induce humoral tolerance to protein therapy in mice. Hum Gene Ther. 2012 Jul; 23(7):769-80.
    View in: PubMed
    Score: 0.005
  38. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver. Blood. 2011 Jun 16; 117(24):6459-68.
    View in: PubMed
    Score: 0.005
  39. Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proc Natl Acad Sci U S A. 2011 Feb 01; 108(5):2082-7.
    View in: PubMed
    Score: 0.005
  40. Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses. Mol Ther. 2008 Sep; 16(9):1546-55.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.